Conformational changes in CD45 upon monoclonal antibody crosslinking

D. Hamann, W. Eichler, H. Fiebig, R. A. van Lier

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)

Abstract

The CD45 protein tyrosine phosphatase is expressed in different isoforms that result from alternative splicing of three exons (A, B, and C) encoding regions near the N-terminus of the extracellular part of the molecule. We describe here a novel epitope on the N-terminal end of CD45 that is recognized by the MAb BL-TSub/2. Crossblocking studies showed that BL-TSub/2 and UCHL1 (CD45RO) binding sites are partially overlapping. However, in marked contrast to the CD45RO epitope, protease treatment of cells strongly diminished BL-TSub/2 binding. Similar to the UCHL1 epitope, the BL-TSub/2 binding site involves carbohydrate moieties, since neuraminidase treatment abrogated the reactivity of the MAb. Markedly, preincubation of cells with both CD45 common and CD45RA MAb induced a pronounced increase of BL-TSub/2 binding. This latter finding suggests that crosslinking of the CD45 molecule leads to conformational changes that could influence association of the molecule with putative ligands
Original languageEnglish
Pages (from-to)11-16
JournalHybridoma (2005)
Volume15
Issue number1
DOIs
Publication statusPublished - 1996

Cite this